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SUMMARY – A case of a 66-year-old man with West Nile neuroinvassive disease manifested 
with fever, weakness, fatigue, consciousness disorders and underlying diabetes mellitus type 2 and 
cardiovascular diseases is presented. Laboratory data showed elevated erythrocyte sedimentation rate 
and fibrinogen. Serological tests revealed West Nile virus specific antibodies of class IgM and IgG in 
serum. West Nile virus RNA was detected in urine sample. Supportive therapy was applied.
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Introduction
West Nile virus (WNV), a single-stranded RNA 
virus, is a mosquito-borne flavivirus (family Flaviviri-
dae)1. The natural cycle is realized by transmission be-
tween mosquitoes of Culex spp. and several bird spe-
cies2. Horses and humans are incidental dead-end 
hosts3. Generally, human infections are asymptomatic, 
acute febrile syndrome is presented in 10%-20% of 
cases, and less than 1% of them developed neuroinva-
sive disease3. The first large outbreak in Europe was in 
Romania in 19964. Since then, sporadic cases were re-
ported until another outbreak occurred in Greece in 
20105. Reports followed on human outbreaks or spo-
radic cases in countries from south-east Europe (Bul-
garia, Croatia, Greece, Romania, Serbia, Turkey)6-13.
A case report of laboratory confirmed human case 
of WNV infection with neurological symptoms and 
favorable outcome is presented.
Case Report
A 66-year-old man presented to the Emergency 
Center, Military Medical Academy, Sofia, Bulgaria, on 
September 7, 2016, because of low-grade fever, palpi-
tation, fatigue, extremity weakness, dizziness, head-
ache, and brief loss of consciousness three days before 
hospital admission. The man had concomitant diabetes 
mellitus type 2, hypertension, paroxysmal atrial fibril-
lation, mitral valve regurgitation and tricuspid valve 
regurgitation. The patient was a retiree and lived in So-
fia. He did outdoor activities such as fishing and hik-
ing and mentioned mosquito bites during the summer 
of 2016. Upon admission, he was afebrile, conscious, 
with blood pressure 150/80 mm Hg, heart rate 90/
min; the rest of physical examination did not show any 
abnormalities. Neurological examination did not esti-
mate neck stiffness or symptoms of Kernig and Brudz-
inski at the time of hospitalization. The main labora-
tory findings were as follows: white blood cell count 
7.3x109/L (reference range: 3.5-10.5 x109/L), platelets 
144x109/L (150-400x109/L), hemoglobin 146 g/L 
(130-180g/L), erythrocyte sedimentation rate 50 mm/h 
(≤20 mm/h), blood glucose 9.4 mmol/L (3.5-5.6 
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mmol/L), creatinine 112 µmol/L (45-130 µmol/L), 
urea 4.7 mmol/L (2.8-8.3 mmol/L), aspartate amino-
transferase 40 IU/L (5-40 IU/L), alanine aminotrans-
ferase 27 IU/L (5-40IU/L), creatine phosphokinase 
193 IU/L (≤180IU/L), C-reactive protein 3.6 mg/L 
(0.0-5.0 mg/L), potassium 4.2 mmol/L (3.5-5.2 
mmol/L), sodium 137 mmol/L (136-145 mmol/L), 
and fibrinogen 5.21 g/L (2.0-4.5g/L). Imaging inves-
tigations were done at the beginning of illness. Elec-
trocardiogram, x-ray and abdominal ultrasound did 
not show any abnormalities. Transthoracic echocar-
diogram revealed the underlying cardiac pathology. 
Empirical antimicrobial drug therapy was started (in-
travenous cefoperazone/sulbactam 1 g twice daily and 
amikacin 500 mg twice daily). The patient received 
supportive treatment as well. In a short period of hos-
pitalization, consciousness disorders developed and 
WNV infection was suspected. The man was trans-
ferred to Department of Infectious Diseases. He be-
came aggressive and excitable with a tendency of 
drowsiness. Neurological examination found right fa-
cial palsy and areflexia of lower extremities. No lumbar 
puncture was performed as the patient refused the in-
vasive procedure. Computed tomography of the head 
was normal. Serum samples were obtained for sero-
logical tests for WNV, TBEV, influenza A virus, influ-
enza B virus and Borrelia burgdorferi. All results were 
negative except for the positive result for specific IgM 
antibodies against WNV in serum sample. On day 7 of 
the illness, second blood and urine samples were ob-
tained and transferred to the National Reference Lab-
oratory of Vector-Borne Infections, Department of 
Microbiology, National Center of Infectious and Para-
sitic Diseases, Sofia, Bulgaria. Specific WNV-IgM an-
tibodies were detected in serum (Anti-WNV ELISA 
IgM, Euroimmun, Lübeck, Germany), but specific 
WNV-IgG antibodies were not found (Anti-WNV 
ELISA IgG, Euroimmun, Lübeck, Germany). Blood 
and urine samples were tested for WNV RNA using a 
commercial kit (Sacace Biotechnologies, Como, Italy). 
The results were negative. One week later, blood and 
urine samples were obtained for confirmation. The 
level of IgM antibodies was elevated and specific IgG 
antibodies against WNV were detected. WNV RNA 
was detected in urine sample by real-time polymerase 
chain reaction (PCR). Blood cultures showed no bac-
terial growth. Neurological manifestations were re-
versible and in a few days the patient regained normal 
consciousness. After complex therapy, the patient was 
discharged. On three-month follow-up, the patient 
was free from any neurological complications.
Discussion
Bulgaria is situated in the south-east part of Eu-
rope, with Mediterranean climate, a field for migratory 
and overwintering birds. During the last decades, the 
neighboring countries reported human WNV out-
breaks and sporadic cases in new areas10-17.
In the 2011-2016 period, the Bulgarian Reference 
Laboratory of Vector-Borne Infections (Sofia, Bul-
garia) reported only nine human cases, of which six 
cases fulfilled the EU criteria for probable WNV cases 
and three cases were laboratory confirmed6-8,18. During 
these six years, only three confirmed human cases at 
the time of increasing emergence of WNV in Europe 
were recorded. It is logically to expect more human 
cases in Bulgaria because of the favorable geographic 
location, suitable climate factors, vectors, and an in-
creasing incidence of cases along the Danube River 
and in northern Greece.
The seroprevalence of WNV among healthy people 
in Bulgaria in 11 provinces of the country showed the 
highest WNV seropositivity in the Sofia district19. Had-
jichristodoulou et al. report 2.1% WNV seropositivity in 
Greece20. Kalaycioglu et al. and Gazi et al. identified se-
roprevalence of WNV in Turkey of 3.8% and 4.3%, re-
spectively21,22. Obviously, the levels of WNV seroposi-
tivity are similar across south-east Europe.
The surveillance systems, veterinary control, medical 
attention to this infection and collaboration among dif-
ferent institutions in Bulgaria are unsatisfactory. Medi-
cal doctors should actively search for WNV infection 
and epidemiological data on mosquito bites in case of 
acute febrile syndrome with/without neurological signs 
in summer/autumn season ( July-October).
The clinical case of WNV infection presented was 
an elderly man with concomitant diseases. Male gen-
der is reported as predominant in Serbian and Roma-
nian reports of WNV cases11,12. Mean age of more than 
65 years and diabetes are significantly associated with 
encephalitis, as reported by Popovic et al.12. Hyperten-
sion is one of the main underlying conditions estimat-
ed in European outbreaks9,11,12. Notably, these con-
comitant diseases increased the chance for WNV 
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manifestation with neuroinvasive disease in patients 
presenting neurological signs, while involvement of 
the nervous system in the development of WNV in-
fection has been recognized as a tendency in the last 
decade in Europe, mainly associated with establish-
ment of WNV lineage 2 in the continent14,23.
In conclusion, a case report of a 66-year-old man 
with underlying diabetes mellitus type 2 and cardio-
vascular diseases, who developed consciousness distur-
bances and neurological signs as a result of neuroinva-
sive infection with WNV is presented. The etiological 
agent was laboratory confirmed based on the EU rec-
ommendation18. Specific antibodies of IgM and IgG 
classes against WNV were found in serum samples. 
WNV RNA was detected by real-time PCR in urine 
sample24. Complex clinical symptoms, physical find-
ings and laboratory investigations confirmed the clini-
cal case of WNV infection in an elderly man with neu-
rological signs, who recovered without consequences.
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Sažetak
INFEKCIJA VIRUSOM ZAPADNOG NILA S NEUROLOšKIM POREMEćAJIMA:  
PRIKAZ SLUčAJA I KRATAK PREGLED STANJA U BUGARSKOJ
M. Baymakova, I. Christova, E. Panayotova, I. Trifonova, A. Chobanov, I. Daskalov, G. T. Popov i K. Plochev
Prikazuje se slučaj 66-godišnjeg bolesnika s neuroinvazivnom bolešću Zapadnog Nila koja se manifestirala groznicom, 
umorom, poremećajem svijesti uz osnovnu bolest dijabetesa tipa 2 i kardiovaskularnom bolešću. Laboratorijski podaci poka-
zali su povišenu sedimentaciju i fibrinogen. Serološki testovi utvrdili su protutijela specifična za virus Zapadnog Nila klase 
IgM i IgG u serumu. Virusna RNA otkrivena je u uzorku mokraće. Primijenjena je suportivna terapija.
Ključne riječi: Virus Zapadnog Nila; Groznica Zapadnog Nila; Antitijela; RNA, virusna; Neurološke bolesti; Prikazi slučaja; 
Bugarska
